A detailed history of Occudo Quantitative Strategies LP transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 15,749 shares of SRTS stock, worth $122,527. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,749
Previous 22,859 31.1%
Holding current value
$122,527
Previous $121,000 24.79%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.93 - $7.05 $35,052 - $50,125
-7,110 Reduced 31.1%
15,749 $91,000
Q2 2024

Aug 14, 2024

BUY
$3.14 - $6.42 $71,777 - $146,754
22,859 New
22,859 $121,000
Q3 2022

Nov 14, 2022

SELL
$7.64 - $14.97 $18,847 - $36,930
-2,467 Reduced 13.56%
15,723 $197,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $11.37 $34,099 - $54,917
4,830 Added 36.15%
18,190 $140,000
Q1 2022

May 16, 2022

BUY
$6.83 - $11.84 $91,248 - $158,182
13,360 New
13,360 $135,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $129M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.